The Daily Scan

June 26, 2018

Last Updated: 9:00 AM EST

​Litigation

  • Caris Healthcare, L.P. and its wholly-owned subsidiary, Caris Healthcare, LLC, have agreed to resolve allegations that they violated the False Claims Act by knowingly submitting false claims, and knowingly retaining overpayments, for the care of patients who were ineligible for the Medicare hospice benefit because they were not terminally ill, the Department of Justice announced yesterday. Under the settlement agreement, Caris Healthcare, a for-profit hospice chain that operates in Tennessee, Virginia, and South Carolina, has agreed to pay $8.5 million. (Justice.gov)

 

  • Equity Forward, which describes itself as a reproductive health watchdog group, filed a lawsuit today after the Department of Health and Human Services failed to respond to four Freedom of Information Act requests, the first being filed in January. The group requested public information including the schedules of HHS officials involved with separated children, communications involving the Office of Refugee Resettlement (ORR), the HHS office in charge of the separated children, and communications between ORR Director Scott Lloyd and outside groups that may have influenced the treatment of children in his care. (TheHill.com)

Regulation

  • The U.S. Food and Drug Administration today approved Epidiolex (cannabidiol) [CBD] oral solution for the treatment of seizures associated with two rare and severe forms of epilepsy, Lennox-Gastaut syndrome and Dravet syndrome, in patients two years of age and older. This is the first FDA-approved drug that contains a purified drug substance derived from marijuana. It is also the first FDA approval of a drug for the treatment of patients with Dravet syndrome. CBD is a chemical component of the Cannabis sativa plant, more commonly known as marijuana. However, CBD does not cause intoxication or euphoria (the “high”) that comes from tetrahydrocannabinol (THC). (FDA.gov)

 

  • Yesterday AMGA’s Board of Directors endorsed a set of value measures designed to simplify the reporting process and limit the burden on providers and group practices, while still reporting clinically relevant and actionable data. The 14 measures were selected to address the flaws with the current quality measurement and reporting system, which suffers from duplicative measures and a lack of data standardization. (BusinessWire.com)

Private Sector

  • As a component of its strategic review, GE announced its plans this morning to create GE Healthcare as a standalone company. Kieran Murphy, president and CEO of GE Healthcare, will continue to lead the organization. GE Healthcare recorded over $19 billion in revenues in 2017 and posted five percent revenue growth and nine percent segment profit growth in the same year. The business provides medical imaging (including contrast agents), monitoring, biomanufacturing and cell therapy technology, leveraging deep digital, artificial intelligence and data analytics capabilities.  Its products and services are valued by customers in 140 countries around the world. (GENewsroom.com)

 

 

 

 

Please reload

Our Recent Posts

The Weekly Scan

April 26, 2019

The Weekly Scan

April 12, 2019

The Weekly Scan

April 5, 2019

1/1
Please reload

Tags

Please reload

 

©2018 by FHAS Inc.

1 PPG Place, 31st Floor,

Pittsburgh, PA 15222